Stifel Financial
EW icon

Stifel Financial’s Edwards Lifesciences EW Stock Holding History

Stifel Financial’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,800
Closed -$27K – 2252
2014
Q2 		$27K Buy
+1,800
New +$24.4K ﹤0.01% 2165

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Stifel Financial's EW Position: Q1 2026 in Review

Stifel Financial increased its Edwards Lifesciences (EW) stake by 10% in Q1 2026, buying an estimated $1.41M and bringing the position to 183,027 shares worth $14.7M. The position accounts for 0.01% of the portfolio, ranked #763.

Stifel Financial first reported a position in EW in Q1 2014 and has held it in 49 quarters since. The position peaked at $52.4M in Q1 2022. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Stifel Financial held 183,027 shares of Edwards Lifesciences worth $14.7M as of Q1 2026.
  • Stifel Financial bought 17,047 Edwards Lifesciences shares in Q1 2026, an estimated $1.41M.
  • Edwards Lifesciences made up 0.01% of Stifel Financial's portfolio in Q1 2026, its #763 holding.
  • Stifel Financial first reported a position in Edwards Lifesciences in Q1 2014 and has held it in 49 quarters since.
  • Stifel Financial's Edwards Lifesciences position peaked at $52.4M in Q1 2022.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.